Physician profile
Luiz H Gonzaga
NPI 1639457575
$275,793.16
in general payments reported to CMS, 2019-2025
5 companies · $62K in 2025
The $62K reported for 2025 was more than what 99% of Prosthodontics providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,698 · 2020: $25K · 2021: $42K · 2022: $48K · 2023: $65K · 2024: $28K · 2025: $62K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $126K · Travel and Lodging: $18K · Consulting Fee: $8,886 · Education: $800 · Gift: $465 · Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $125,779.02 |
| Travel and Lodging | $17,949.40 |
| Consulting Fee | $8,886.00 |
| Education | $800.00 |
| Gift | $465.30 |
| Food and Beverage | $403.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $249,282.15 | 2019-2025 | |
| Geistlich Pharma, North America, INC. | $25,877.77 | 2019-2025 | Bio-Materials, Bio-Gide |
| Meisinger USA, LLC | $465.30 | 2024 | Ma19, Bmp00031 |
| Ivoclar Vivadent, INC. | $146.44 | 2021 | |
| Dentsply Sirona INC | $21.50 | 2024 | Astra Tech Implant System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luiz Gonzaga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.